Immunome (IMNM) is back in focus after announcing that Phase 3 data for its desmoid tumor drug candidate, varegacestat, will be featured in an oral session at the 2026 ASCO Annual Meeting. The company ...

Paraguay’s Investor Pass Signals a Strategic Shift in Global Capital Attraction A country once known for offering one of the ...

Former Navy SEAL John Doolittle says the military must move from reactive care to predictive readiness using data and human ...

The REAP grant and loan program and the clean energy tax credit have been rolled back under the Trump administration.

Dogwood Therapeutics, Inc. is one of the oversold biotech stocks on this list. TheFly reported on April 15 that DWTX ...

If you've ever wondered how grocery store bakeries are able to compete in pricing with smaller, family-owned bakeries, we had ...

Last September, the American Wagyu Association rolled out a new program, certified by the U.S. Department of Agriculture, to ...

TheFly reported on April 7 that H.C. Wainwright increased its price target on ENLV from $13 to $20 while maintaining a Buy ...

Looking to set up an immersive theater-like experience for when you're using the big screen at home? Look no further than ...

The Tennessee House is considering last-minute amendments that would link the state's two private school tuition subsidy ...

If you've noticed that it’s actually pretty cheap to park on the street in downtown Orlando, that’s because parking rates — ...